NEWS

MEDIA

[KOREA PHARM & BIO 2022] Mepsgen introduces its booth at KOREA PHARM & BIO 2022

[KOREA PHARM & BIO 2022] Mepsgen introduces its booth at KOREA PHARM & BIO 2022

2022-06-13

[YOUTUBE] MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"

[YOUTUBE] MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"

2022-06-03

MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"

MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"

2022-05-13

[BIO KOREA 2022] Mepsgen introduces its booth at BIO KOREA 2022

[BIO KOREA 2022] Mepsgen introduces its booth at BIO KOREA 2022

2022-05-11

MEPSGEN became a new member of Korea Bio Technology Industry Organization (KOREABIO)

MEPSGEN became a new member of Korea Bio Technology Industry Organization (KOREABIO)

2022-04-20

MEPSGEN-OSONG Medical Innovation Foundation, Finished well the policy/academic symposium of high-tech validation of alternative methods.

MEPSGEN-OSONG Medical Innovation Foundation, Finished well the policy/academic symposium of high-tech validation of alternative methods.

2022-04-05

OK-MPS VC & KBIOHealth 첨단대체시험법 TF 공동심포지엄

OK-MPS VC & KBIOHealth 첨단대체시험법 TF 공동심포지엄

2022-04-05

Mepsgen CEO YongTae Kim delivered the development status at the Korea Bio Investment Conference 2021(KBIC 2021) held at the Seoul Dragon city in Seoul.

Mepsgen CEO YongTae Kim delivered the development status at the Korea Bio Investment Conference 2021(KBIC 2021) held at the Seoul Dragon city in Seoul.

2021-12-07

Mepsgen starts mass production of its Human organ on a chip MEPS-TBC

Mepsgen starts mass production of its Human organ on a chip MEPS-TBC

2021-11-22

“New drug development need to revaluate the risk of failure”

“New drug development need to revaluate the risk of failure”

2021-11-12

Seoul Bio Economy Forum 2021 _ Mepsgen, a startup in a journey to commercialization of organ-on-a-chip technology

Seoul Bio Economy Forum 2021 _ Mepsgen, a startup in a journey to commercialization of organ-on-a-chip technology

2021-10-29

MEPSGEN is going to become a new company which lead not only Organ-on-a-Chip but also new drug development

MEPSGEN is going to become a new company which lead not only Organ-on-a-Chip but also new drug development

2021-10-24

MIT professor Robert Langer joined Mepsgen as a Co-Founder

MIT professor Robert Langer joined Mepsgen as a Co-Founder

2021-10-11

Biotech startup Mepsgen closed the series A bridge

Biotech startup Mepsgen closed the series A bridge

2021-09-18

Mepsgen Human Organ-on-a-Chip company, The countdown to the series A bridge!

Mepsgen Human Organ-on-a-Chip company, The countdown to the series A bridge!

2021-09-02

Moderna founder Robert Langer “Global biotech like Moderna can come out of Republic of Korea”

Moderna founder Robert Langer “Global biotech like Moderna can come out of Republic of Korea”

2021-06-17

Moderna founder Robert Langer is a scientific advisor of Mepsgen

Moderna founder Robert Langer is a scientific advisor of Mepsgen

2021-06-13

Mepsgen developing human organ model chips overcomes the limitations of animal models

Mepsgen developing human organ model chips overcomes the limitations of animal models

2021-04-27

Industry news: 2020 high-impact publications in the BDM area

Industry news: 2020 high-impact publications in the BDM area

2021-01-05

Mepsgen alzheimer's treatment company participated ‘Bio Investment Conference by the Korea Economic Daily ‘

Mepsgen alzheimer's treatment company participated ‘Bio Investment Conference by the Korea Economic Daily ‘

2020-12-30

Sitemap닫기

PRODUCT
MEPS-X
ProMEPS™
MST-X
PIPELINE
MG-X_Nanomedicine
TECHNOLOGY
MICROPHYSIOLOGICAL SYSTEM (MPS)
NANOPARTICLE PRODUCTION
NANOMEDICINE
SERVICE
RESEARCH SERVICE
RESEARCH EQUIPMENT
ABOUT
OVERVIEW
VISION
HISTORY
LOCATIONS
PARTNERSHIP
CONTACT
NEWS
NOTICE
MEDIA
ARTICLE
CAREERS
CULTURE
HIRING
PROCESS
WE'RE HIRING!